Before You Take An Eye Formula With Vitamin A And Zinc: Pregnancy, Children And Other Times To Ask First
For most healthy adults, an eye formula that names vitamin A and zinc without saying how much or in what form is an irritation. For a smaller group of people it is the whole question. This article is about who they are, what the research says about each case, and why a bottle that prints no form and no amount cannot answer it.
- Preformed vitamin A at high intakes is linked to birth defects. The threshold is debated, which is exactly why the amount and form matter for anyone who is pregnant or might become so.
- Children and teenagers have lower upper limits than adults, and this product is described for adults only.
- Vitamin A is stored in the liver, and the risk margin is narrower with liver disease and heavy alcohol use.
- In kidney disease both nutrients behave differently, so the decision belongs with the person managing the kidneys.
- Any supplement should be named to the surgeon and the eye doctor before a procedure.
- The Visivra label prints neither a form nor an amount, so none of these questions can be answered from the bottle.
Why missing numbers matter more for some people
Nothing in this article is a reason to think that a bottle of Visivra is harmful to a healthy adult. That is not what the evidence shows, and it is not the claim. The claim is narrower: for a handful of situations, the safe answer depends on two facts the label does not give.
The first fact is the form of the vitamin A. Preformed vitamin A means retinol and its esters, and it is the form with an established upper limit. The alternative, a provitamin such as beta carotene, is a different molecule with a different research history. The vitamin A article covers the difference. Here it is enough to say the Visivra artwork names Vitamin A and stops.
The second fact is the amount. The upper intake level for preformed vitamin A in adults, set by the US Institute of Medicine in its 2001 report, is 3,000 micrograms of retinol activity equivalents a day from all sources, and the equivalent for zinc in adults is 40 mg a day. These are ceilings for the total from food, supplements and everything else taken together. A ceiling can only be checked against a number, and the number is the thing not printed.
None of the amounts in this article is a Visivra amount. Where a figure appears, it is what a named study or a named reference used.
Pregnancy, and the weeks before you know
Pregnancy is where the vitamin A question has the highest stakes, and where the evidence needs to be told fairly, including the part that is uncertain.
What the largest study found
In 1995, Rothman and colleagues published a study in the New England Journal of Medicine that followed 22,748 pregnant women. Nurse interviewers had asked about diet, medicines and illness in the first trimester, and outcomes were collected afterwards. Of the 22,748, 339 had babies with birth defects, and 121 of those defects were in tissue that comes from the cranial neural crest, the same tissue affected by the synthetic retinoid drugs known to cause birth defects.
For those defects, the prevalence among babies of women who took more than 10,000 IU a day of preformed vitamin A from supplements was 4.8 times that among babies of women taking 5,000 IU or less (95 percent confidence interval 2.2 to 10.5). A smoothed curve suggested an apparent threshold near 10,000 IU a day of supplemental vitamin A, and the excess was concentrated among women who took high amounts before the seventh week of pregnancy. The authors estimated that among babies born to women taking more than 10,000 IU of supplemental preformed vitamin A a day, about one in 57 had a malformation attributable to the supplement.
For context, 10,000 IU of retinol is 3,000 micrograms of retinol activity equivalents, which is the adult upper intake level quoted above. The two numbers meet.
What complicates it
A single study does not close a question, and this one has not gone unchallenged. A separate case-control study by Mills and colleagues, published in 1997 in the American Journal of Obstetrics and Gynecology, interviewed women whose pregnancies produced babies with neural tube defects, with other major malformations, and normal controls. It found no association between periconceptional vitamin A at more than 8,000 or more than 10,000 IU a day and malformations, including the cranial neural crest defects. The authors concluded that if vitamin A is a teratogen, the minimum dose appears well above what most women consume.
In a 1998 review in Reproductive Toxicology, Miller and colleagues tried to draw the line. They wrote that doses of 10,000 IU a day or less of preformed vitamin A are considered safe, that doses above 10,000 IU a day as supplements had been linked to malformations in a single epidemiologic study, and that daily exposures above 25,000 IU had not been studied enough to establish a specific risk. Their practical recommendation was that women in industrialised countries with adequate diets may not need to take more than the Recommended Dietary Allowance of preformed vitamin A as a supplement.
MedlinePlus, the US National Library of Medicine's consumer encyclopedia, puts the plain version this way: large doses of vitamin A in pregnant women can cause birth defects. It also gives the daily recommended amount for adult women aged 19 to 50 in pregnancy as 770 micrograms.
One more figure belongs here. The same 3,000 microgram ceiling applies in pregnancy for women aged 19 and over, and 2,800 micrograms for pregnant teenagers aged 14 to 18, according to the Institute of Medicine report.
What that adds up to
The honest summary is that the risk is dose-dependent, that the exact threshold is argued over, and that the argument is the reason to take it seriously rather than to dismiss it. Nobody sensible builds a plan around the lucky end of a disputed range. The people this affects have two features in common: the possible harm falls on a developing baby, and the sensitive window can begin before a pregnancy is confirmed.
That second point is easy to miss. Rothman's excess was concentrated in the first weeks. Someone who is trying to conceive, or who could conceive, is in the group that needs the form and amount before starting, not after a test turns positive. If a prenatal vitamin is already part of the picture, note that many prenatal products also contain vitamin A and zinc, so a second product adds to a total rather than replacing one. Only the person's midwife, obstetrician or pharmacist can add those up, and they can only do it with the numbers.
The Visivra artwork names vitamin A and gives no form and no amount. Whether the vitamin A is preformed, and how much of it there is, cannot be read from the bottle. For anyone who is pregnant, trying to become pregnant or might be, that unanswered question is enough on its own to ask a clinician before opening a bottle. The site's own who-it-is-for page reaches the same position.
Breastfeeding
Breastfeeding raises the body's need for vitamin A rather than lowering it, which is why it is easy to assume more is better. MedlinePlus lists the recommended daily amount during breastfeeding for adult women as 1,300 micrograms, higher than the 700 micrograms for adult women generally. That is a recommended intake and not a licence to add a supplement of unknown strength: the upper intake level of 3,000 micrograms of preformed vitamin A still applies to the total.
There is far less research on eye-formula ingredients specifically in nursing mothers than on pregnancy, and none of the studies cited in this article set out to study it. The reasonable position is the same as for pregnancy: the person's clinician can weigh the whole diet and any existing vitamins, and can do so only when the form and amount are known.
Children and teenagers
The Visivra product is described for adults, and the trials cited in these articles were conducted in adults. That is a reason in itself for it not to be given to a child. The vitamin A numbers give a second reason.
MedlinePlus notes that babies and children are more sensitive to vitamin A than adults and can become ill after taking much smaller amounts. The recommended daily amounts show why: 300 micrograms for ages one to three, 400 for four to eight, and 600 for nine to thirteen, against 900 for adult men and 700 for adult women. The Institute of Medicine's upper limits for preformed vitamin A follow the same downward slope by age: 600 micrograms for ages one to three, 900 for four to eight, 1,700 for nine to thirteen and 2,800 for teenagers aged 14 to 18, against 3,000 for adults.
So the ceiling for a young child is far below the adult figure. A capsule designed around an adult, with an adult's total intake in mind, is not simply a smaller dose away from being suitable. A teenager falls into a grey area that a paediatrician, not a bottle, should settle. A child's eyesight worries, from squinting to headaches after reading, are best taken to an eye examination, because the common causes of those problems are things a capsule does not treat.
Liver disease and heavy alcohol use
Vitamin A that is not needed does not leave the body quickly. It is stored, mostly in the liver, and that is why long-term intake matters more than a single day's.
The clearest picture of what excess does to the liver comes from a case series. Geubel and colleagues examined 41 consecutive patients with vitamin A liver damage. The cause was suspected at the first interview in only 13; in the rest, it was found on biopsy. Seventeen had cirrhosis, ten had mild chronic hepatitis and five had portal hypertension without cirrhosis, and six died of liver-related causes over an average follow-up of 4.6 years. In those cases the smallest continuous daily intake that led to cirrhosis was 25,000 IU over six years. Those intakes are well above the adult ceiling of 10,000 IU, and the paper is not evidence that an eye capsule does this. It is evidence that the liver damage from long-term overuse is real, slow and easy to miss.
Alcohol changes the margin. In a 1999 review in the American Journal of Clinical Nutrition, Leo and Lieber described how alcohol and retinol share metabolic pathways. Prolonged drinking depletes vitamin A stores, yet correcting that with supplements is complicated, because the liver toxicity of retinol is potentiated by concomitant alcohol. In their words, alcohol narrows the therapeutic window. A more recent 2025 review of vitamin A toxicity and the liver describes the progression from fatty liver to fibrosis and cirrhosis, and lists limiting vitamin A intake among the steps in management.
The practical reading is proportionate. A healthy adult who drinks moderately has no special reason for alarm. A person with known liver disease, or one who drinks heavily, is in the group for whom the vitamin A total matters most, and they are also the people least able to learn that total from a label without a number. Their hepatologist or general practitioner should see the product before it is started.
Kidney disease
Kidney disease complicates both nutrients, in opposite directions.
Vitamin A
Blood levels of vitamin A tend to be higher when kidney function is lower. A 2025 study in PLOS ONE by Toffalini and colleagues measured vitamin A in 200 outpatients with type 2 diabetes and found levels above the normal range in 29 percent of them; estimated kidney filtration rate was an independent predictor of a high level. A 2024 analysis of 689 people with chronic kidney disease in the US National Health and Nutrition Examination Survey found that a higher serum vitamin A level was independently related to all-cause mortality, and the authors called the vitamin A requirement in kidney disease worth further study.
Both are observational. A high blood level in someone with poor kidney function does not by itself show that supplements caused harm, and it certainly does not show that a supplement would. What it does show is that vitamin A is not handled the same way, and that the number of a supplement is something a nephrologist would want to see.
Zinc
Zinc cuts the other way. A 2026 systematic review and meta-analysis of randomised trials in adults with chronic kidney disease, in Nutrition Reviews, opens by noting that zinc deficiency is prevalent in chronic kidney disease. Across 23 meta-analysed studies, zinc supplementation raised serum zinc, body weight, HDL cholesterol, albumin and dietary energy intake, with no significant effect on several other measures; the authors rated the overall evidence as low quality.
That is a useful example of why the answer is individual. Someone with kidney disease may be short of zinc and may also carry excess vitamin A, so one capsule containing both could help one number and hurt another. The person deciding is the one who reads the blood tests, and they need the amounts to do it.
Zinc on its own
Zinc has one long-known risk when taken well above the ceiling for a long time: it can lower copper. Willis and colleagues described three men with zinc-induced copper deficiency, presenting with anaemia, low white blood cells and, in two, a progressive nerve problem, all of it traced to excess zinc. These are case reports of excess zinc, not of ordinary intakes. The zinc and copper article takes this up in full, including why the trial formulas that used high zinc added copper alongside it.
The point for this article is who it applies to. Anyone already taking a zinc-containing product, whether a cold remedy, a multivitamin, a prenatal vitamin or a denture adhesive, has an existing total, and adding a capsule with an unstated amount adds an unknown to it.
Before surgery, including eye surgery
If a procedure is planned, the surgical and anaesthetic team should be told about every supplement, and that includes cataract and other eye surgery.
The most-cited review on the subject, Ang-Lee, Moss and Yuan in JAMA, was about herbal medicines rather than vitamins and minerals, and it named eight herbs with documented perioperative concerns, such as bleeding with garlic, ginkgo and ginseng. Its recommendation applies more widely: at the pre-operative assessment, physicians should explicitly elicit and document any use of these products. It helps a great deal if the patient volunteers it first.
None of the eight herbs that review named is an ingredient in this formula, and nothing cited here says otherwise about the six names on this label. The team decides whether anything needs pausing, and it can only decide what it knows about. Bring the bottle, or a photo of the label and the vendor's ingredient list, and be aware that the label gives them very little to work with.
The questions to bring
Whichever of these situations applies, the useful step is the same: get the specification before the first capsule. These are the questions that settle it.
- What form is the vitamin A? Retinol or retinyl esters, which count toward the preformed ceiling, or a provitamin such as beta carotene, which does not.
- How much vitamin A is in one capsule, and in what unit? Micrograms of retinol activity equivalents, or IU, and how many capsules make a day.
- What form and amount of zinc? Oxide, gluconate, citrate and others carry different amounts of elemental zinc per milligram of compound.
- Is there copper in it? The label names none.
- What else do I already take that contains vitamin A or zinc? Multivitamin, prenatal vitamin, cod liver oil, cold lozenges.
- Does my clinician want a written specification? If so, ask the seller through the contact page, and do not start until it arrives.
This article cannot tell you whether a particular capsule is right for you, and no article can. What it can do is name the situations where the missing numbers stop being a footnote. If none of them describes you, the general reading in the side effects page is the place to continue.
Settle the two questions, then decide about Visivra
Six named actives and 30 capsules a bottle. Get the vitamin A form and the amounts in writing first if any of the situations above is yours.
Order VisivraReferences
- Rothman KJ, Moore LL, Singer MR, Nguyen US, Mannino S, Milunsky A. Teratogenicity of high vitamin A intake. N Engl J Med. 1995;333(21):1369-73. PMID 7477116. https://pubmed.ncbi.nlm.nih.gov/7477116/
- Mills JL, Simpson JL, Cunningham GC, Conley MR, Rhoads GG. Vitamin A and birth defects. Am J Obstet Gynecol. 1997;177(1):31-6. PMID 9240579. https://pubmed.ncbi.nlm.nih.gov/9240579/
- Miller RK, Hendrickx AG, Mills JL, Hummler H, Wiegand UW. Periconceptional vitamin A use: how much is teratogenic? Reprod Toxicol. 1998;12(1):75-88. PMID 9431575. https://pubmed.ncbi.nlm.nih.gov/9431575/
- Geubel AP, De Galocsy C, Alves N, Rahier J, Dive C. Liver damage caused by therapeutic vitamin A administration: estimate of dose-related toxicity in 41 cases. Gastroenterology. 1991;100(6):1701-9. PMID 2019375. https://pubmed.ncbi.nlm.nih.gov/2019375/
- Leo MA, Lieber CS. Alcohol, vitamin A, and beta-carotene: adverse interactions, including hepatotoxicity and carcinogenicity. Am J Clin Nutr. 1999;69(6):1071-85. PMID 10357725. https://pubmed.ncbi.nlm.nih.gov/10357725/
- Pestalardo ML, Bevilacqua CS, Amante MF. Vitamin A toxicity and hepatic pathology: a comprehensive review. World J Hepatol. 2025;17(8):107738. PMID 40901583. https://pubmed.ncbi.nlm.nih.gov/40901583/
- Toffalini A, Vigolo N, Sani E, et al. Hypervitaminosis A in type 2 diabetes and its relation with renal function and cardiovascular complications. PLoS One. 2025;20(10):e0333407. PMID 41052073. https://pubmed.ncbi.nlm.nih.gov/41052073/
- Feng Y, Li Y, Chen S, Hu N, Liao D. Vitamin A is associated with all-cause mortality in patients with chronic kidney disease: a population-based cohort study. Front Nutr. 2024;11:1469844. PMID 39698241. https://pubmed.ncbi.nlm.nih.gov/39698241/
- Tan NLX, Young M, Lambert K, Dawson J. Impact of zinc supplementation in adults with chronic kidney disease: a systematic review and meta-analysis of randomized controlled trials. Nutr Rev. 2026. PMID 41651464. https://pubmed.ncbi.nlm.nih.gov/41651464/
- Willis MS, Monaghan SA, Miller ML, et al. Zinc-induced copper deficiency: a report of three cases initially recognized on bone marrow examination. Am J Clin Pathol. 2005;123(1):125-31. PMID 15762288. https://pubmed.ncbi.nlm.nih.gov/15762288/
- Ang-Lee MK, Moss J, Yuan CS. Herbal medicines and perioperative care. JAMA. 2001;286(2):208-16. PMID 11448284. https://pubmed.ncbi.nlm.nih.gov/11448284/
- Institute of Medicine (US) Panel on Micronutrients. Vitamin A. In: Dietary Reference Intakes for Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium, and Zinc. Washington (DC): National Academies Press; 2001. https://www.ncbi.nlm.nih.gov/books/NBK222318/
- MedlinePlus Medical Encyclopedia. Vitamin A. U.S. National Library of Medicine; review date January 21, 2025. https://medlineplus.gov/ency/article/002400.htm